The U.S. Food and Drug Administration (FDA) reported on Friday that early findings suggest cinnamon may be the culprit behind elevated lead levels in fruit puree pouches, causing illness in 34 children.
The Food and Drug Administration (FDA) has issued a warning concerning 27 eye drop products, raising concerns about their sterility and potential risk of causing eye infections. Major retailers like CVS Health, Walmart, Target, and several others were included in this advisory. Of these, Leader (Cardinal Health) has initiated a recall in response to the FDA’s alert.
A case involving an off-duty pilot attempting to interfere with a flight after taking “magic mushrooms” highlights cautionary advice from experts.
The U.S. Food and Drug Administration (FDA) has given the green light to updated COVID-19 booster shots from Pfizer and Moderna, marking a significant development in the ongoing battle against the virus. These booster shots are designed to combat the XBB.1.5 Omicron subvariant, are fully approved for individuals aged 12 and older, and are authorized for emergency use in those aged 6 months through 11 years.
Veopoz (pozelimab-bbfg) injection, a complement inhibitor, has received FDA approval for managing CD55-deficient protein-losing enteropathy (PLE), or CHAPLE disease, in patients aged one year and above. This marks the pioneering FDA-approved therapy for CHAPLE disease. Initially, Veopoz is administered intravenously, followed by weekly subcutaneous injections supervised by a healthcare professional. For comprehensive dosing instructions, refer to the prescribing information.
In a potential breakthrough, two novel Alzheimer’s drugs are showcasing encouraging outcomes in slowing down the progression of the disease during its early stages. Recent research has unveiled promising results about the effectiveness of a fresh Eli Lilly medication, known as Donanemab, in curbing the advancement of Alzheimer’s by approximately 35%. For individuals in the … Read more
Pfizer’s groundbreaking RSV vaccine tailored for infants, known as Abrysvo, has successfully secured approval from the Food and Drug Administration (FDA).
Responsible for triggering up to 80,000 pediatric hospitalizations and 300 pediatric fatalities annually in the United States, the respiratory syncytial virus (RSV) is a significant health concern. While most infants who contract RSV experience mild respiratory symptoms such as congestion, cough, and fatigue, there’s a subset that encounters breathing difficulties and potential complications like pneumonia.
The US Food and Drug Administration (FDA) has granted approval for the medication zuranolone to treat postpartum depression, making it the first FDA-approved oral pill for this specific condition in the United States. Postpartum depression is a serious mental illness that can affect about 1 in 7 new mothers after childbirth.
Artificial intelligence-driven ultrasounds are on the cusp of revolutionizing routine prenatal care as Sonio Detect, an AI-powered ultrasound scanning technology, becomes the first of its kind to receive FDA approval.